Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Medpace Holdings, Inc.

Cash and Cash Equivalents

Cash and Cash Equivalents %Chg

Cash and Cash Equivalents Common Size

Restricted Cash

Restricted Cash %Chg

Restricted Cash Common Size

Accounts Receivable and Unbilled, Net

Accounts Receivable and Unbilled, Net %Chg

Accounts Receivable and Unbilled, Net Common Size

Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets %Chg

Prepaid Expenses and Other Current Assets Common Size

Total Current Assets

Total Current Assets %Chg

Total Current Assets Common Size

Property and Equipment, Net

Property and Equipment, Net %Chg

Property and Equipment, Net Common Size

Operating Lease Right-of-Use Assets

Operating Lease Right-of-Use Assets %Chg

Operating Lease Right-of-Use Assets Common Size

Goodwill

Goodwill %Chg

Goodwill Common Size

Intangible Assets, Net

Intangible Assets, Net %Chg

Intangible Assets, Net Common Size

Deferred Income Taxes

Deferred Income Taxes %Chg

Deferred Income Taxes Common Size

Other Assets

Other Assets %Chg

Other Assets Common Size

Total Assets

Total Assets %Chg

Total Assets Common Size

Accounts Payable

Accounts Payable %Chg

Accounts Payable Common Size

Pre-Funded Study Costs

Pre-Funded Study Costs %Chg

Pre-Funded Study Costs Common Size

Advanced Billings

Advanced Billings %Chg

Advanced Billings Common Size

Accrued Expenses

Accrued Expenses %Chg

Accrued Expenses Common Size

Short-Term Debt

Short-Term Debt %Chg

Short-Term Debt Common Size

Other Current Liabilities

Other Current Liabilities %Chg

Other Current Liabilities Common Size

Total Current Liabilities

Total Current Liabilities %Chg

Total Current Liabilities Common Size

Long-Term Debt, Net, Less Current Portion

Long-Term Debt, Net, Less Current Portion %Chg

Long-Term Debt, Net, Less Current Portion Common Size

Operating Lease Liabilities

Operating Lease Liabilities %Chg

Operating Lease Liabilities Common Size

Deemed Landlord Liability, Less Current Portion

Deemed Landlord Liability, Less Current Portion %Chg

Deemed Landlord Liability, Less Current Portion Common Size

Deferred Income Tax Liability

Deferred Income Tax Liability %Chg

Deferred Income Tax Liability Common Size

Deferred Credit

Deferred Credit %Chg

Deferred Credit Common Size

Other Long-Term Liabilities

Other Long-Term Liabilities %Chg

Other Long-Term Liabilities Common Size

Total Liabilities

Total Liabilities %Chg

Total Liabilities Common Size

Common Stock

Common Stock %Chg

Common Stock Common Size

Treasury Stock

Treasury Stock %Chg

Treasury Stock Common Size

Additional Paid-in Capital

Additional Paid-in Capital %Chg

Additional Paid-in Capital Common Size

Retained Earnings

Retained Earnings %Chg

Retained Earnings Common Size

Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Loss %Chg

Accumulated Other Comprehensive Loss Common Size

Total Shareholders' Equity

Total Cash and Cash Equivalents

Total Cash and Cash Equivalents %Chg

Total Cash and Cash Equivalents Common Size

Accounts Receivable

Accounts Receivable %Chg

Accounts Receivable Common Size

Total Trade Receivables

Total Trade Receivables %Chg

Total Trade Receivables Common Size

Other Current Assets

Other Current Assets %Chg

Other Current Assets Common Size

Net Property, Plant & Equipment

Net Property, Plant & Equipment %Chg

Net Property, Plant & Equipment Common Size

Net Intangible Assets

Net Intangible Assets %Chg

Net Intangible Assets Common Size

Other Long-Term Assets

Other Long-Term Assets %Chg

Other Long-Term Assets Common Size

Unearned Revenue

Unearned Revenue %Chg

Unearned Revenue Common Size

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Assets	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Cash and Cash Equivalents	46.3	669.4	510.9	245.4	39.1	28.3
Cash and Cash Equivalents
Total Cash and Cash Equivalents	46.3	669.4	510.9	245.4	39.1	28.3
Accounts Receivable	377.9	296.4	301.1	298.4	275.1	253.4
Accounts Receivable and Unbilled, Net
Total Trade Receivables	377.9	296.4	301.1	298.4	275.1	253.4
Other Current Assets	96.6	63.4	60.5	50	64.7	52.3
Restricted Cash
Prepaid Expenses and Other Current Assets
Total Current Assets	520.8	1,029.2	872.5	593.8	378.9	334
Net Property, Plant & Equipment	265	252.3	256.4	265.4	254.7	248.9
Property and Equipment, Net
Operating Lease Right-of-Use Assets
Net Intangible Assets	33.9	34.4	35.1	35.8	36.9	38
Intangible Assets, Net
Goodwill	662.4	662.4	662.4	662.4	662.4	662.4
Goodwill
Other Long-Term Assets	89.6	122.6	93.6	99.4	74	69.2
Deferred Income Taxes
Other Assets
Total Assets	1,571.7	2,100.9	1,920	1,656.8	1,406.9	1,352.5

Liabilities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Accounts Payable	43.3	32.5	27.4	31.9	33.6	33.1
Accounts Payable
Accrued Expenses	323.5	307.8	292.7	293	231.9	210.1
Accrued Expenses
Short-Term Debt	—	—	—	—	55	50
Short-Term Debt
Unearned Revenue	808.8	710.6	638.4	559.9	490.6	462.7
Pre-Funded Study Costs
Advanced Billings
Pre-Funded Study Costs
Advanced Billings
Other Current Liabilities	44.9	53.6	34.6	40.4	41.3	47.5
Other Current Liabilities
Total Current Liabilities	1,220.4	1,104.6	993.1	925.1	852.4	803.5
Long-Term Debt	—	—	—	—	—	—
Long-Term Debt, Net, Less Current Portion
Leases	124.9	126.2	131.8	142.1	139.4	138.9
Operating Lease Liabilities
Other Long-Term Liabilities	53.9	44.5	31.6	30.6	24.1	23.8
Deemed Landlord Liability, Less Current Portion
Deferred Income Tax Liability
Deferred Credit
Other Long-Term Liabilities
Total Long-Term Liabilities	178.9	170.8	163.4	172.7	163.4	162.6
Total Liabilities	1,399.3	1,275.3	1,156.4	1,097.9	1,015.9	966.1

Equity	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Common Stock	0.3	0.3	0.3	0.3	0.3	0.3
Common Stock
Treasury Stock	-12.2	-12.2	-12.2	-12.3	-12.3	-12.5
Treasury Stock
Additional Paid-in Capital	893.2	844.1	818.9	802.7	785.3	770.8
Additional Paid-in Capital
Accumulated Other Comprehensive Income	-5.7	-14.7	-12.6	-10.1	-11.2	-12.4
Accumulated Other Comprehensive Loss
Retained Earnings	-703.2	8.2	-30.8	-221.6	-371	-359.8
Retained Earnings
Total Common Shareholders' Equity	172.4	825.5	763.6	559	391.1	386.4
Total Shareholders' Equity	172.4	825.5	763.6	559	391.1	386.4
Total Liabilities and Shareholders' Equity	1,571.7	2,100.9	1,920	1,656.8	1,406.9	1,352.5
Total Liabilities and Shareholders' Equity